Chengdu Easton Biopharmaceuticals (688513) Income Statement & Earnings

59.00
-0.54-0.91%

Market Closed Jan 16 15:00 CST

10.42BMarket Cap43.16P/E (TTM)

Chengdu Easton Biopharmaceuticals (688513) Income Statement

All

YOY

Hide blank lines

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

Total operating revenue

-2.00%1.02B

-2.25%654.45M

-2.97%305.64M

20.82%1.35B

22.38%1.04B

20.56%669.51M

13.37%314.99M

-4.56%1.12B

-5.33%849.78M

-3.48%555.36M

Operating revenue

-2.00%1.02B

-2.25%654.45M

-2.97%305.64M

20.82%1.35B

22.38%1.04B

20.56%669.51M

13.37%314.99M

-4.56%1.12B

-5.33%849.78M

-3.48%555.36M

Total operating cost

-3.27%830.69M

0.47%546.06M

0.50%259.52M

22.07%1.16B

24.26%858.79M

21.38%543.48M

14.04%258.24M

-4.73%951.86M

-6.88%691.11M

-3.24%447.75M

Operating cost

6.12%247.74M

6.17%158.32M

0.25%63.71M

51.58%338.45M

45.98%233.45M

49.61%149.13M

26.28%63.55M

13.91%223.27M

13.79%159.92M

10.36%99.68M

Operating tax surcharges

-2.04%15.42M

-9.98%9.31M

-15.22%4.18M

17.75%20.99M

17.17%15.74M

18.78%10.35M

12.29%4.93M

-1.78%17.83M

6.89%13.44M

7.17%8.71M

Operating expense

-9.44%320.48M

-12.47%207.06M

-4.35%110.62M

15.92%445.79M

23.25%353.89M

24.17%236.57M

12.63%115.64M

-18.89%384.56M

-21.51%287.13M

-18.23%190.52M

Administration expense

-6.25%68.49M

4.00%45.21M

4.18%21.74M

8.37%107.15M

1.60%73.06M

-8.98%43.47M

-9.75%20.87M

9.49%98.87M

11.23%71.91M

30.23%47.76M

Financial expense

13.50%-4.75M

32.59%-3.35M

-93.66%-1.83M

-28.34%-14.32M

45.42%-5.49M

12.35%-4.96M

77.27%-944.57K

-8.94%-11.16M

-54.61%-10.06M

-20.27%-5.66M

-Interest expense (Financial expense)

-36.50%1.89M

-41.53%1.28M

-26.23%720.34K

7.75%3.68M

19.38%2.98M

38.68%2.18M

34.69%976.43K

31.15%3.42M

82.32%2.49M

158.78%1.57M

-Interest Income (Financial expense)

16.64%-6.97M

31.92%-4.68M

-26.31%-2.61M

-19.36%-17.54M

34.09%-8.36M

4.47%-6.88M

58.10%-2.06M

-14.44%-14.7M

-57.75%-12.68M

-34.06%-7.2M

Research and development

-2.57%183.3M

18.88%129.5M

12.76%61.1M

10.64%263.86M

11.47%188.13M

2.06%108.93M

8.18%54.18M

3.34%238.49M

2.23%168.77M

7.43%106.74M

Credit Impairment Loss

67.19%-1.94M

90.53%-512.88K

100.12%2.8K

-893.97%-3.05M

-642.72%-5.92M

-487.47%-5.42M

-6,106.33%-2.31M

125.57%384.48K

47.52%-796.4K

135.39%1.4M

Asset Impairment Loss

-117.52%-3.79M

-61.26%-1.08M

-350.03%-804.91K

-116.95%-5.7M

-96.30%-1.74M

-52.01%-669.63K

32.52%-178.86K

-13.41%-2.63M

58.65%-886.68K

55.06%-440.52K

Other net revenue

Fair value change income

-1.20%13.34M

-24.89%6.84M

8.80%3.44M

2.45%14.92M

0.01%13.5M

14.07%9.1M

-23.25%3.16M

-27.13%14.57M

-34.71%13.5M

-44.65%7.98M

Invest income

-47.89%2.5M

-11.87%4.05M

-67.41%1.02M

-9.79%9.84M

-13.66%4.79M

-9.32%4.59M

45.80%3.13M

38.95%10.91M

48.66%5.55M

81.72%5.07M

-Including: Investment income associates

-301.37%-2.22M

-171.84%-501.87K

-3,443.03%-386.47K

-1,080.16%-1.41M

-464.08%-552.56K

427.16%698.61K

-88.29%11.56K

-72.51%144.33K

--151.77K

--132.52K

Asset deal income

1,169.28%24.53K

----

-102.24%-2.99K

-116.70%-2.29K

---2.29K

-48.20%133.29K

--13.74K

Other revenue

8.57%43.18M

23.09%31.95M

-35.47%12.69M

-9.40%48.12M

12.37%39.77M

12.47%25.95M

80.25%19.67M

-18.25%53.11M

1.79%35.39M

36.97%23.08M

Operating profit

4.41%241.76M

-6.24%149.62M

-22.13%62.47M

4.24%251.98M

9.51%231.55M

10.29%159.59M

17.49%80.22M

-7.25%241.74M

0.23%211.44M

-1.10%144.7M

Add:Non operating Income

4,537.13%433.65K

28,383.24%193.48K

3,538.12%9.79K

1,232.64%1.39M

-90.84%9.35K

-94.59%679.27

-89.17%269.18

-93.18%104.22K

-80.19%102.14K

-18.28%12.56K

Less:Non operating expense

-48.31%99.43K

-40.15%80.89K

-48.97%66.33K

287.52%781.03K

135.51%192.37K

163.71%135.16K

218.70%129.97K

20.81%201.55K

-46.62%81.68K

-66.49%51.26K

Total profit

4.63%242.09M

-6.10%149.74M

-22.07%62.41M

4.53%252.59M

9.41%231.37M

10.23%159.46M

17.37%80.09M

-7.77%241.64M

0.07%211.46M

-1.03%144.66M

Less:Income tax cost

52.85%21.93M

1.55%13.17M

-64.14%1.82M

-4.72%14.35M

-19.16%14.35M

-1.34%12.96M

-29.95%5.08M

-2.60%15.07M

12.20%17.75M

13.89%13.14M

Net profit

1.45%220.16M

-6.77%136.57M

-19.22%60.59M

5.15%238.23M

12.03%217.02M

11.38%146.49M

23.00%75.01M

-8.09%226.57M

-0.91%193.72M

-2.31%131.52M

Net profit from continuing operation

1.45%220.16M

-6.77%136.57M

-19.22%60.59M

5.15%238.23M

12.03%217.02M

11.38%146.49M

23.00%75.01M

-8.09%226.57M

-0.91%193.72M

-2.31%131.52M

Net profit of parent company owners

1.45%220.16M

-6.77%136.57M

-19.22%60.59M

5.15%238.23M

12.03%217.02M

11.38%146.49M

23.00%75.01M

-8.09%226.57M

-0.91%193.72M

-2.31%131.52M

Earning per share

Basic earning per share

0.81%1.25

-7.23%0.77

-20.93%0.34

6.25%1.36

12.73%1.24

10.67%0.83

-15.69%0.43

-37.56%1.28

-32.52%1.1

-33.04%0.75

Diluted earning per share

0.81%1.25

-7.23%0.77

-20.93%0.34

6.25%1.36

12.73%1.24

10.67%0.83

-15.69%0.43

-37.56%1.28

-32.52%1.1

-33.04%0.75

Other composite income

Total composite income

1.45%220.16M

-6.77%136.57M

-19.22%60.59M

5.15%238.23M

12.03%217.02M

11.38%146.49M

23.00%75.01M

-8.09%226.57M

-0.91%193.72M

-2.31%131.52M

Total composite income of parent company owners

1.45%220.16M

-6.77%136.57M

-19.22%60.59M

5.15%238.23M

12.03%217.02M

11.38%146.49M

23.00%75.01M

-8.09%226.57M

-0.91%193.72M

-2.31%131.52M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Zhonghui Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023
Total operating revenue	-2.00%1.02B	-2.25%654.45M	-2.97%305.64M	20.82%1.35B	22.38%1.04B	20.56%669.51M	13.37%314.99M	-4.56%1.12B	-5.33%849.78M	-3.48%555.36M
Operating revenue	-2.00%1.02B	-2.25%654.45M	-2.97%305.64M	20.82%1.35B	22.38%1.04B	20.56%669.51M	13.37%314.99M	-4.56%1.12B	-5.33%849.78M	-3.48%555.36M
Total operating cost	-3.27%830.69M	0.47%546.06M	0.50%259.52M	22.07%1.16B	24.26%858.79M	21.38%543.48M	14.04%258.24M	-4.73%951.86M	-6.88%691.11M	-3.24%447.75M
Operating cost	6.12%247.74M	6.17%158.32M	0.25%63.71M	51.58%338.45M	45.98%233.45M	49.61%149.13M	26.28%63.55M	13.91%223.27M	13.79%159.92M	10.36%99.68M
Operating tax surcharges	-2.04%15.42M	-9.98%9.31M	-15.22%4.18M	17.75%20.99M	17.17%15.74M	18.78%10.35M	12.29%4.93M	-1.78%17.83M	6.89%13.44M	7.17%8.71M
Operating expense	-9.44%320.48M	-12.47%207.06M	-4.35%110.62M	15.92%445.79M	23.25%353.89M	24.17%236.57M	12.63%115.64M	-18.89%384.56M	-21.51%287.13M	-18.23%190.52M
Administration expense	-6.25%68.49M	4.00%45.21M	4.18%21.74M	8.37%107.15M	1.60%73.06M	-8.98%43.47M	-9.75%20.87M	9.49%98.87M	11.23%71.91M	30.23%47.76M
Financial expense	13.50%-4.75M	32.59%-3.35M	-93.66%-1.83M	-28.34%-14.32M	45.42%-5.49M	12.35%-4.96M	77.27%-944.57K	-8.94%-11.16M	-54.61%-10.06M	-20.27%-5.66M
-Interest expense (Financial expense)	-36.50%1.89M	-41.53%1.28M	-26.23%720.34K	7.75%3.68M	19.38%2.98M	38.68%2.18M	34.69%976.43K	31.15%3.42M	82.32%2.49M	158.78%1.57M
-Interest Income (Financial expense)	16.64%-6.97M	31.92%-4.68M	-26.31%-2.61M	-19.36%-17.54M	34.09%-8.36M	4.47%-6.88M	58.10%-2.06M	-14.44%-14.7M	-57.75%-12.68M	-34.06%-7.2M
Research and development	-2.57%183.3M	18.88%129.5M	12.76%61.1M	10.64%263.86M	11.47%188.13M	2.06%108.93M	8.18%54.18M	3.34%238.49M	2.23%168.77M	7.43%106.74M
Credit Impairment Loss	67.19%-1.94M	90.53%-512.88K	100.12%2.8K	-893.97%-3.05M	-642.72%-5.92M	-487.47%-5.42M	-6,106.33%-2.31M	125.57%384.48K	47.52%-796.4K	135.39%1.4M
Asset Impairment Loss	-117.52%-3.79M	-61.26%-1.08M	-350.03%-804.91K	-116.95%-5.7M	-96.30%-1.74M	-52.01%-669.63K	32.52%-178.86K	-13.41%-2.63M	58.65%-886.68K	55.06%-440.52K
Other net revenue
Fair value change income	-1.20%13.34M	-24.89%6.84M	8.80%3.44M	2.45%14.92M	0.01%13.5M	14.07%9.1M	-23.25%3.16M	-27.13%14.57M	-34.71%13.5M	-44.65%7.98M
Invest income	-47.89%2.5M	-11.87%4.05M	-67.41%1.02M	-9.79%9.84M	-13.66%4.79M	-9.32%4.59M	45.80%3.13M	38.95%10.91M	48.66%5.55M	81.72%5.07M
-Including: Investment income associates	-301.37%-2.22M	-171.84%-501.87K	-3,443.03%-386.47K	-1,080.16%-1.41M	-464.08%-552.56K	427.16%698.61K	-88.29%11.56K	-72.51%144.33K	--151.77K	--132.52K
Asset deal income	1,169.28%24.53K	----	----	-102.24%-2.99K	-116.70%-2.29K	-116.70%-2.29K	---2.29K	-48.20%133.29K	--13.74K	--13.74K
Other revenue	8.57%43.18M	23.09%31.95M	-35.47%12.69M	-9.40%48.12M	12.37%39.77M	12.47%25.95M	80.25%19.67M	-18.25%53.11M	1.79%35.39M	36.97%23.08M
Operating profit	4.41%241.76M	-6.24%149.62M	-22.13%62.47M	4.24%251.98M	9.51%231.55M	10.29%159.59M	17.49%80.22M	-7.25%241.74M	0.23%211.44M	-1.10%144.7M
Add:Non operating Income	4,537.13%433.65K	28,383.24%193.48K	3,538.12%9.79K	1,232.64%1.39M	-90.84%9.35K	-94.59%679.27	-89.17%269.18	-93.18%104.22K	-80.19%102.14K	-18.28%12.56K
Less:Non operating expense	-48.31%99.43K	-40.15%80.89K	-48.97%66.33K	287.52%781.03K	135.51%192.37K	163.71%135.16K	218.70%129.97K	20.81%201.55K	-46.62%81.68K	-66.49%51.26K
Total profit	4.63%242.09M	-6.10%149.74M	-22.07%62.41M	4.53%252.59M	9.41%231.37M	10.23%159.46M	17.37%80.09M	-7.77%241.64M	0.07%211.46M	-1.03%144.66M
Less:Income tax cost	52.85%21.93M	1.55%13.17M	-64.14%1.82M	-4.72%14.35M	-19.16%14.35M	-1.34%12.96M	-29.95%5.08M	-2.60%15.07M	12.20%17.75M	13.89%13.14M
Net profit	1.45%220.16M	-6.77%136.57M	-19.22%60.59M	5.15%238.23M	12.03%217.02M	11.38%146.49M	23.00%75.01M	-8.09%226.57M	-0.91%193.72M	-2.31%131.52M
Net profit from continuing operation	1.45%220.16M	-6.77%136.57M	-19.22%60.59M	5.15%238.23M	12.03%217.02M	11.38%146.49M	23.00%75.01M	-8.09%226.57M	-0.91%193.72M	-2.31%131.52M
Net profit of parent company owners	1.45%220.16M	-6.77%136.57M	-19.22%60.59M	5.15%238.23M	12.03%217.02M	11.38%146.49M	23.00%75.01M	-8.09%226.57M	-0.91%193.72M	-2.31%131.52M
Earning per share
Basic earning per share	0.81%1.25	-7.23%0.77	-20.93%0.34	6.25%1.36	12.73%1.24	10.67%0.83	-15.69%0.43	-37.56%1.28	-32.52%1.1	-33.04%0.75
Diluted earning per share	0.81%1.25	-7.23%0.77	-20.93%0.34	6.25%1.36	12.73%1.24	10.67%0.83	-15.69%0.43	-37.56%1.28	-32.52%1.1	-33.04%0.75
Other composite income
Total composite income	1.45%220.16M	-6.77%136.57M	-19.22%60.59M	5.15%238.23M	12.03%217.02M	11.38%146.49M	23.00%75.01M	-8.09%226.57M	-0.91%193.72M	-2.31%131.52M
Total composite income of parent company owners	1.45%220.16M	-6.77%136.57M	-19.22%60.59M	5.15%238.23M	12.03%217.02M	11.38%146.49M	23.00%75.01M	-8.09%226.57M	-0.91%193.72M	-2.31%131.52M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	--	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	--	--	--	--	Zhonghui Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"